Literature DB >> 17729123

Investigating the free radical trapping ability of NXY-059, S-PBN and PBN.

Helen E Williams1, Mike Claybourn, A Richard Green.   

Abstract

The spin trapping ability of the nitrones 2,4-disulphophenyl-N-tert-butyl nitrone (NXY-059), 2-sulphophenyl-N-tert-butyl nitrone (S-PBN) and alpha-phenyl-N-tert-butyl nitrone (PBN) for both hydroxyl and methanol radicals was investigated using electron paramagnetic resonance (EPR) spectroscopy. The radicals of interest were generated in situ in the spectrometer under constant flow conditions in the presence of each nitrone. The spin adducts formed were detected by EPR spectroscopy. This approach allowed for quantitative comparison of the EPR spectra of the spin adducts of each nitrone. The results obtained showed that NXY-059 trapped a greater number of hydroxyl and methanol radicals than the other two nitrones, under the conditions studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729123     DOI: 10.1080/10715760701557161

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  15 in total

Review 1.  Anti-cancer activity of nitrones and observations on mechanism of action.

Authors:  Robert A Floyd; Hema K Chandru; Ting He; Rheal Towner
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

2.  OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.

Authors:  Patricia Coutinho de Souza; Nataliya Smith; Oluwatomisin Atolagbe; Jadith Ziegler; Charity Njoku; Megan Lerner; Marilyn Ehrenshaft; Ronald P Mason; Bill Meek; Scott M Plafker; Debra Saunders; Nadezda Mamedova; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2015-06-26       Impact factor: 7.376

Review 3.  Translational research involving oxidative stress and diseases of aging.

Authors:  Robert A Floyd; Rheal A Towner; Ting He; Kenneth Hensley; Kirk R Maples
Journal:  Free Radic Biol Med       Date:  2011-04-14       Impact factor: 7.376

4.  Alpha-phenyl-N-tert-butylnitrone (PBN) prevents light-induced degeneration of the retina by inhibiting RPE65 protein isomerohydrolase activity.

Authors:  Md Nawajes A Mandal; Gennadiy P Moiseyev; Michael H Elliott; Anne Kasus-Jacobi; Xiaoman Li; Hui Chen; Lixin Zheng; Olga Nikolaeva; Robert A Floyd; Jian-Xing Ma; Robert E Anderson
Journal:  J Biol Chem       Date:  2011-07-24       Impact factor: 5.157

5.  The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro.

Authors:  N J Mutch; N R Moore; C Mattsson; H Jonasson; A R Green; N A Booth
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

6.  Effects of NXY-059 in experimental stroke: an individual animal meta-analysis.

Authors:  P M W Bath; L J Gray; A J G Bath; A Buchan; T Miyata; A R Green
Journal:  Br J Pharmacol       Date:  2009-04-27       Impact factor: 8.739

7.  OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.

Authors:  Patricia Coutinho de Souza; Nataliya Smith; Richard Pody; Ting He; Charity Njoku; Robert Silasi-Mansat; Florea Lupu; Bill Meek; Hong Chen; Yunzhou Dong; Debra Saunders; Albert Orock; Erik Hodges; Sarah Colijn; Nadezda Mamedova; Rheal A Towner
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

Review 8.  Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.

Authors:  A R Green
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 9.  Preclinical Studies and Translational Applications of Intracerebral Hemorrhage.

Authors:  Felix Siaw-Debrah; Mark Nyanzu; Haoqi Ni; Xiao Lin; Zhu Xu; Linhui Ruan; Qichuan Zhuge; Lijie Huang
Journal:  Biomed Res Int       Date:  2017-06-18       Impact factor: 3.411

Review 10.  How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?

Authors:  Kazutoshi Watanabe; Masahiko Tanaka; Satoshi Yuki; Manabu Hirai; Yorihiro Yamamoto
Journal:  J Clin Biochem Nutr       Date:  2017-11-11       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.